- The report contains detailed information about Galenica Ltd. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Galenica Ltd.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Galenica Ltd. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Galenica Ltd. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Galenica Ltd. business.
About Galenica Ltd.
Galenica Ltd., through its subsidiaries, operates as a diversified healthcare company primarily in Switzerland, Europe, and the Americas. The company engages in the development, manufacture, and marketing of pharmaceutical products; runs pharmacies; provides logistical and database services; and sets up networks. It operates in four segments: Pharma, Logistics, Retail, and Other. The Pharma segment develops, produces, and markets pharmaceutical products worldwide. It focuses on iron deficiency anaemia and consumer healthcare, a range of prescription and non-prescription products and herbal remedies; markets products manufactured by third parties; and develops and markets CellCept for applications in auto-immune diseases. The Logistics segment provides services for pre-wholesale pharmaceutical companies, including storage and distribution; supplies healthcare products to pharmacies, physicians, drugstores, and hospitals; and provides marketing support to its customers. The Retail segment owns and operates a chain of pharmacies. As of December 31, 2009, it operated 268 stores and 109 partner pharmacies. This segment operated a chain of pharmacies under the Amavita brand in 121 locations; 101 pharmacies under the Sun Store brand; 39 own sales points in partnership with Coop under the Coop Vitality brand; and 109 Winconcept partner pharmacies. The Other segment offers solutions for the networked healthcare market that include the databases, which provide knowledge for the service providers in the Swiss healthcare market, and develop management solutions for the networked healthcare market. It also provides master data systems for healthcare market; and publishes printed and electronic technical information on pharmaceutical products in Switzerland. The company was formerly known as Collaboration Pharmaceutique SA and changed its name to Galenica Ltd. in 1932. Galenica Ltd. was founded in 1927 and is headquartered in Berne, Switzerland.
RESEARCH METHODOLOGY
DISCLAIMER
1. GALENICA LTD. COMPANY PROFILE
1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. GALENICA LTD. BUSINESS OVERVIEW
2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. GALENICA LTD. SWOT ANALYSIS
3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats
4. GALENICA LTD. FINANCIAL ANALYSIS
4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. GALENICA LTD. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Galenica Ltd. Direct Competitors
5.2. Comparison of Galenica Ltd. and Direct Competitors Financial Ratios
5.3. Comparison of Galenica Ltd. and Direct Competitors Stock Charts
5.4. Galenica Ltd. Industry Analysis
5.4.1. Healthcare Services Industry Snapshot
5.4.2. Galenica Ltd. Industry Position Analysis
6. GALENICA LTD. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. GALENICA LTD. EXPERTS REVIEW*
7.1. Experts Opinion
7.2. Experts Estimates
APPENDIX 1: RATIO DEFINITIONS
LIST OF TABLES
Galenica Ltd. Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Galenica Ltd. Key Executives
Key Executives Biographies*
Key Executives Compensations*
Galenica Ltd. Major Shareholders
Galenica Ltd. History
Galenica Ltd. Products
Revenues by Product
Revenues by Region
Galenica Ltd. Offices and Representations
Galenica Ltd. SWOT Analysis
Income Statement 2009-2012 Including 4-years Trends
Income Statement Latest 4 Quarters Including Trends
Balance Sheet 2009-2012 Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Cash Flow 2009-2012 Including Trends
Cash Flow Latest 4 Quarters Including Trends
Galenica Ltd. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Galenica Ltd. Capital Market Snapshot
Galenica Ltd. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Services Industry Statistics
Galenica Ltd. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Galenica Ltd. Consensus Recommendations*
Analyst Recommendation Summary*
Price Target Summary*
Experts Recommendation Trends*
Revenue Estimates Analysis*
Earnings Estimates Analysis*
Historical Surprises*
Revenue Estimates Trend*
Earnings Estimates Trend*
Revenue Revisions*
Earnings Revisions*
LIST OF FIGURES
Galenica Ltd. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Galenica Ltd. 1-year Stock Charts
Galenica Ltd. 5-year Stock Charts
Galenica Ltd. vs. Main Indexes 1-year Stock Chart
Galenica Ltd. vs. Direct Competitors 1-year Stock Charts
Galenica Ltd. Article Density Chart
* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.
The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.